Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

591 ARTÍCULOS , VIENDO DEL 46 AL 60

Antibody Therapies for Alzheimer's Disease: A New Strategy for Targeted Therapy and Blood-Brain Barrier Delivery

Feng X, Wang H.

ACS Chem Neurosci. 2025 Sep 17;16(18):3450-3464. doi: 10.1021/acschemneuro.5c00484. Epub 2025 Sep 7.

Integrating molecular imaging with near-infrared theranostics to improve early detection and therapy of Alzheimer's disease

Mahajan G, Pandya K, Tripathi A, Kumar D.

Bioorg Chem. 2025 Oct;165:108949. doi: 10.1016/j.bioorg.2025.108949. Epub 2025 Sep 11.

Alzheimer's Disease: From Molecular Mechanisms to Promising Therapeutic Strategies

Ivanova AV, Kutuzova AD, Kuzmichev IA, Abakumov MA.

Int J Mol Sci. 2025 Sep 26;26(19):9444. doi: 10.3390/ijms26199444.

Unraveling the Significance of Fecal MicroRNA Profile in Alzheimer's Disease

Katuwawala K, Bharadwaj P, Martins I, De Silva BGDNK, Ho V, Dissanayake A, Martins RN, Fernando WMADB.

Mol Neurobiol. 2025 Dec 22;63(1):319. doi: 10.1007/s12035-025-05626-6.

Cognitive resilience in Alzheimer's disease: Mechanism and potential clinical intervention

Jia B, Xu Y, Zhu X.

Ageing Res Rev. 2025 Apr;106:102711. doi: 10.1016/j.arr.2025.102711. Epub 2025 Feb 26.

Knowledge and Attitude of Nurses in Wuxi, China Towards Alzheimer's Disease: A Cross-Sectional Study

Wang R, Gu Y, Yang H, Ge S, Cai Y, Wan X.

Nurs Open. 2025 Apr;12(4):e70199. doi: 10.1002/nop2.70199.

Decoding Alzheimer's Disease: Single-Cell Sequencing Uncovers Brain Cell Heterogeneity and Pathogenesis

Ma YN, Xia Y, Karako K, Song P, Tang W, Hu X.

Mol Neurobiol. 2025 Nov;62(11):14459-14473. doi: 10.1007/s12035-025-04997-0. Epub 2025 Apr 30.

Cross-Species Framework for Emotional Well-Being and Brain Aging: Lessons From Behavioral Neuroscience

Lin FV, Simmons JM, Turnbull A, Zuo Y, Conwell Y, Wang KH.

JAMA Psychiatry. 2025 Jul 1;82(7):734-741. doi: 10.1001/jamapsychiatry.2025.0581.

Falls in people with Alzheimer's disease: Exploring the role of inhibitory control

Wells M, Alty J, Hinder MR, St George RJ.

Neurosci Biobehav Rev. 2025 Aug;175:106228. doi: 10.1016/j.neubiorev.2025.106228. Epub 2025 May 22.

A Narrative Review Evaluating Diet and Exercise as Complementary Medicine for the Management of Alzheimer's Disease

Szabo-Reed AN, Key MN.

Nutrients. 2025 May 26;17(11):1804. doi: 10.3390/nu17111804.

Clinical Decision Support for Alzheimer's: Challenges in Generalizable Data-Driven Approach

Gao T, Madanian S, Templeton J, Merkin A.

Stud Health Technol Inform. 2025 Aug 7;329:1780-1781. doi: 10.3233/SHTI251211.

Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus

Rico V, Zelinsky M, Ford PJ, Leverenz J, Pillai JA, Miller JB, Martinez K, Lerner AJ, Tousi B, Apostolova LG, Arias JJ, Bolton CJ, Brewer AA, Bridgeman K, Burns JM, Butler T, Dierickx K, Erickson CM, Festari C, Fitri FI, Fowler NR, Gale SA, Gao C, Gallagher MD, Johnson KG, Morris JK, Porteri C, Qiu C, Rahman-Filipiak A, Rahemi Z, Richard E, Schaeverbeke J, Stern Y, Suver C, Trenaman S, Blasi MT, Vandenberghe R, Walter S, Williams K, Sankary LR.

J Alzheimers Dis. 2025 Nov;108(2):703-718. doi: 10.1177/13872877251379076. Epub 2025 Sep 25.

Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer's disease

Benussi A, Agosta F, Alfano AR, Antico A, Bellelli G, Bonanni L, Bottini G, Bozzali M, Brignoli O, Bruno G, Cagnin A, Calloni SF, Cecchin D, Ciaccio M, Cocozza S, Cosottini M, De Leo D, Falini A, Gaetani L, Gotta F, Infantino M, Lodi R, Logroscino G, Marcello E, Marra C, Marrocco W, Mecocci P, Mossello E, Padovani A, Palleschi L, Pantoni L, Parnetti L, Sorbi S, Tessitore A, Ungar A.

Neurol Sci. 2025 Dec;46(12):6875-6894. doi: 10.1007/s10072-025-08576-y. Epub 2025 Oct 17.

Deep learning for Alzheimer's disease: advances in classification, segmentation, subtyping, and explainability

Shaikh MR, Jeyabose A, Arjunan RV.

Biomed Eng Online. 2025 Dec 29;24(1):150. doi: 10.1186/s12938-025-01482-6.

Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid-β PET Retention

Shimasaki R, Kurihara M, Ishibashi K, Tokumaru AM, Ishii K, Iwata A.

Ann Clin Transl Neurol. 2025 Jul;12(7):1506-1510. doi: 10.1002/acn3.70025. Epub 2025 Mar 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias